What is Vasthera?

A start-up pharmaceutical company that develops the first-in-class
synthetic therapeutics targeting the vascular hyperplasia.

What is Vasthera?

A start-up pharmaceutical company that develops the first-in-class
synthetic therapeutics targeting the vascular hyperplasia.

Pipelines

  • Pulmonary arterial hypertension (PAH) is a form of pulmonary hypertension, which shows high blood pressure in the lung arteries.
  • After a stent installs in the atherosclerotic coronary arteries, the neointimal hyperplasia called in-stent restenosis occurs.
  • Angina, also known as angina pectoris, is chest pain or pressure, usually due to not enough blood flow to the heart muscle by the clogging or hardening of coronary arteries. Myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops to a part of the heart by the rupture of coronary arterial vessels, causing damage to the heart muscle.
  • Atherosclerosis is a disease in which the inside of an artery narrows due to the build up of plaque.
  • Heart failure (HF), also known as chronic heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Signs and symptoms of heart failure commonly include shortness of breath, excessive tiredness, and leg swelling.

R & D

  • In vitro enzyme study

  • Chemical Screening

  • In vivo study

News/Events

FAMILY SITE
Top ▲

Room #504, Science Bldg. C, 52, Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea

Copyright ⓒ VASTHERA. All rights reserved